" class="no-js "lang="en-US"> AdipoPharma - Medtech Alert
Thursday, March 28, 2024

AdipoPharma

About AdipoPharma

AdipoPharma

Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation. The goal? Reducing weight and restoring metabolic balance for millions of people living with diabetes.

Related Story

Adipopharma’s First-in-class Candidate - PATAS - Shows Improvement in Whole-body Insulin Resistance and Associated Comorbidities in Vivo

July 15 2022

AdipoPharma, formerly ALMS Therapeutics SAS, a biopharmaceutical company focused on innovative peptide-based approaches to treating […]